Search contract descriptions, companies and agencies.
DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES
Total Committed
$15.7M
Product or Service Description
Biomedical Applied Research/Exploratory Development R&D
Contracting Agency
Effective Date
Sept. 18, 2020
Funding Department
NATIONAL INSTITUTES OF HEALTH NIAID
Type
Cost plus fixed fee
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| BATTELLE MEMORIAL INSTITUTE | CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES | March 4, 2021 | Supplemental Agreement For Work Within Scope | $0 |
| BATTELLE MEMORIAL INSTITUTE | CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES | Feb. 10, 2021 | Supplemental Agreement For Work Within Scope | $0 |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | Jan. 22, 2021 | Supplemental Agreement For Work Within Scope | $777,104 |
| BATTELLE MEMORIAL INSTITUTE | IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST EMERGING INFECTIOUS DISEASES INCLUDING COVID-19 (SARS-C0V2) | Dec. 2, 2020 | Exercise An Option | $1,064,710 |
| BATTELLE MEMORIAL INSTITUTE | IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST EMERGING INFECTIOUS DISEASES INCLUDING COVID-19 (SARS-C0V2) | Nov. 10, 2020 | Supplemental Agreement For Work Within Scope | $0 |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | Nov. 10, 2020 | Supplemental Agreement For Work Within Scope | $252,370 |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | Sept. 23, 2020 | Supplemental Agreement For Work Within Scope | $0 |
| BATTELLE MEMORIAL INSTITUTE | CLINICAL AND NHP SAMPLE TESTING FOR SARS-COV-2 VACCINE AND OTHER BIOLOGICAL PRODUCT CANDIDATES | Sept. 18, 2020 | Supplemental Agreement For Work Within Scope | $98,800 |
| BATTELLE MEMORIAL INSTITUTE | CLINICAL AND NHP SAMPLE TESTING FOR SARS-COV-2 VACCINE AND OTHER BIOLOGICAL PRODUCT CANDIDATES | Aug. 21, 2020 | $1,005,452 | |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | Aug. 13, 2020 | Supplemental Agreement For Work Within Scope | $1,457,965 |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | July 20, 2020 | Supplemental Agreement For Work Within Scope | $5,636,058 |
| BATTELLE MEMORIAL INSTITUTE | IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST EMERGING INFECTIOUS DISEASES INCLUDING COVID-19 (SARS-C0V2) | June 10, 2020 | Supplemental Agreement For Work Within Scope | $0 |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | May 28, 2020 | Exercise An Option | $695,714 |
| BATTELLE MEMORIAL INSTITUTE | IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST EMERGING INFECTIOUS DISEASES INCLUDING COVID-19 (SARS-C0V2) | April 21, 2020 | $2,429,847 | |
| BATTELLE MEMORIAL INSTITUTE | DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES | April 21, 2020 | $2,254,547 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.